•••> With the overall downtrend during the past couple of months, it is easy to make the mistake of believing that GRCU is destined to continue the downward drift into oblivion. Although every stock has a unique chart, below I have posted the chart of another company (NTE*) which I believe demonstrates similar price movement as GRCU, and also demonstrates the upside potential once consolidation has occurred.

After bottoming at under one tenth of a penny in late Nov '12, an uptrend began in NTE* which brought it to copperland. After peaking at nearly 3 cents in early Feb '13 (up thousands of percent from the Nov bottom), it spent the next few months drifting downward, and stood at about a penny a share in mid May '13.

So after peaking at around .03, it had lost two thirds of the extraordinary gains over the next few months. At that point, those still holding had to be concerned that is might drop back into the sub-pennies never to return to copperland.

Just as with NTE*, GRCU had quickly run from tripps to multipennies, only to drift back down to about a penny a few short months later.

But just as NTE* holders were likely beginning to lose hope, those who continued to hold were in store for an extraordinary run... one that would dwarf the original run which had peaked at 3 cents. After drifting back down to the 1 cent level, NTE* went on to hit a high of 13 cents per share a couple of months later, and then ran to 17 cents per share about 4 months after that.

So my point is that after a massive move upward (such as GRCU has made), from the land of triple zeros, price consolidation is almost always a necessary evil. It allows shareholders with an entry price far lower than the current share price to be replaced with newer buyers much closer to the current price. This process, as most already know, provides a much more stable foundation, allowing for higher highs on the next run.

Although anything can happen with the respect to share price in OTC land, it is my opinion that we'll be seeing new 52 week highs for the GRCU share price within the next few months.

As always, simply my opinion.



GRCU

I've just added another 400k shs, mainly because of Quirk's previous (marketing) leadership role in the Minute Maid division of Coca Cola.

IMO, all that would be required for a 10x move from this level (currently .0005) is for the juice product to be launched. And I expect some sort of launch event by Halloween.

FPFI

It appears as though even the ancient stone masons were trying to convey a message to us regarding their recommendation to buy/hold Green Cures Inc.



As always, simply my opinion.

GRCU

These archaeologists must not even take time off for the holidays. Apparently they've uncovered another important ancient artifact, relating to Green Cures. They also appear to bullish on the cannabis industry.



As a reminder, below is the first important discovery relating to Green Cures...

Very witty, RickNagra. Rumor has it that the ancient Egyptians placed their order through PharoahTrade. And they didn't bid-sit... they were slapping the ask. Meanwhile, those who missed out on the opportunity were slapping the asp (egyptian cobra).

Thanks again for the suggestion regarding reposting the GRCU comparison to the other explosive chart. It took me a while to locate, but finally I found it.

This is perhaps the greatest find since the Rosetta stone...

An ancient tablet, with extensive hieroglyphics, was reportedly discovered by some archeologists. One of the archeologists, a savy OTC investor in his spare time, uncovered a secret message embedded in the tablet. Some are speculating that it is a 'buy' recommendation for Green Cures and Botanical Distribution Inc. (GRCU)...



GRCU

{::::}> With the overall downtrend during the past couple of months, it is easy to make the mistake of believing that GRCU is destined to continue the downward drift into oblivion. Although every stock has a unique chart, below I have posted the chart of another company (NTE*) which I believe demonstrates similar price movement as GRCU, and also demonstrates the upside potential once consolidation has occurred.

After bottoming at under one tenth of a penny in late Nov '12, an uptrend began in NTE* which brought it to copperland. After peaking at nearly 3 cents in early Feb '13 (up thousands of percent from the Nov bottom), it spent the next few months drifting downward, and stood at about a penny a share in mid May '13.

So after peaking at around .03, it had lost two thirds of the extraordinary gains over the next few months. At that point, those still holding had to be concerned that is might drop back into the sub-pennies never to return to copperland.

Just as with NTE*, GRCU had quickly run from tripps to multipennies, only to drift back down to about a penny a few short months later.

But just as NTE* holders were likely beginning to lose hope, those who continued to hold were in store for an extraordinary run... one that would dwarf the original run which had peaked at 3 cents. After drifting back down to the 1 cent level, NTE* went on to hit a high of 13 cents per share a couple of months later, and then ran to 17 cents per share about 4 months after that.

So my point is that after a massive move upward (such as GRCU has made), from the land of triple zeros, price consolidation is almost always a necessary evil. It allows shareholders with an entry price far lower than the current share price to be replaced with newer buyers much closer to the current price. This process, as most already know, provides a much more stable foundation, allowing for higher highs on the next run.

Although anything can happen with the respect to share price in OTC land, it is my opinion that we'll be seeing new 52 week highs for the GRCU share price within the next few months.

As always, simply my opinion.



GRCU

The genesis of the explosive price move that GRCU has had, and some of my thoughts on the subject. As painful as this price consolidation near a penny is, IMO it has been a necessary evil over the past few months, for the following reasons.

During the period of Aug 2012 thru Dec 2013, GRCU (formerly TTDZ) traded in the low triple zeros (see chart below). That's 5 complete fiscal quarters of a trading range within the low triple zeros. During that extended period of time, there was least a couple billion shares traded, which represented the entire share structure for the company.

With the entire share structure having been traded in the low triple zero range between Aug 2012 and Dec 2013, there is a very high probability that the vast majority of shareholders had an entry price in the low triple zeros, prior to the price explosion.

Within the 3 month period of Jan 1 2014 and April 1 2014, the share price then ran from .0002 to 4.9 cents. That's a 240x move, which is more than 24,000%. And since that move was preceded by trading of several billion in the low triple zeros which was more than the entire share structure, the huge move upward likely left many original shareholders with huge gains from the triple zero level.

Had the share price been in the low triple zero level only briefly (as some of the OTC stocks experience prior to a huge move), there would not be a large number of shareholder sitting on gains of tens of thousands of percent. But as we know from the historical chart (see below), there was a period well in excess of a year with the stock trading in the low triple zeros for shares to be acquired.

I think it is because of this price history that we have been seeing the stock drift downward over the past few months. I believe that on most days, there's probably a couple of million shares that were originally picked up in the low triple zeros being sold at the bid. While some are questioning why would some people be selling each day with such future potential, the answer is that even around one penny, an original low triple zero buyer is clearing 20 to 50x their original purchase amount. And with an uncertain future, and a declining stock price, who could blame them.

I do believe that most of those original buyers (with an entry point in the low triple zeros) have been flushed from the system, and we should begin to see share price appreciation in the near future.

As always simply my opinion.



GRCU

Thanks for reminding me, RickNagra. I believe the chart below is the one to which you refer. It shows consolidation very similar to the type GRCU is currently going through, as well as what occurred following the consolidation.

While some continue to focus on GRCU's pullback from 4.9 cents to around a penny, others are more focused on what's to come. It is very common for a stock that blasts from sub-penny to multiple pennies within a very short timeframe, to then pull back and consolidate right around a penny. Once that consolidation is compete, it is not uncommon for the stock to then surpass the previous multipenny high on the next run (given the right combination of catalysts).

One such example is Nte*, which had a huge run from deep in the subpennies to about 3 cents, and then painfully drifted back to around a penny a share (during a period of about 5 months). Many were shaken out of their positions during that consolidation.

Others held through the consolidation storm, and were very glad they did. Less than two months later (by early July of 2013), the stock not only stopped the bleeding, but ran to nearly 18 cents, up about 1700% from the level it was at on May 21 '13 when it dipped below a penny (during its consolidation phase).

IMO, once Robert Calkin gets all of his ducks in a row, the coming run will be bigger than the first.

GRCU

Thanks BOBMOTBA. Agreed... written into history, and perhaps the greatest discovery since the Rosetta stone. It is preordained. Green Cures soon to unleash awe-inspiring gains.

This is really unbelievable...
An ancient tablet, with extensive hieroglyphics, was reportedly discovered by some archeologists. One of the archeologists, a savy OTC investor in his spare time, uncovered a secret message embedded in the tablet. Some are speculating that it is a 'buy' recommendation for Green Cures and Botanical Distribution Inc. (GRCU)...



GRCU

stervc, very well stated. We are in complete agreement here.

Accountants do not typically audit quarterly financial statements, they conduct an audit on a complete fiscal year. Green Cures has not completed a complete fiscal year of operations, since taking over the old TTD% corporate entity.

Even companies such as Apple Inc and Walmart make it very clear on their quarterly financial statements that they are unaudited. I have included links below to the filings of their unaudited quarterly financial statements, in support of what is industry standard with respect to financial statement audits. And as pointed out by others, Green Cures would not be required to file audited financials, regardless, because of their corporate classification.

http://www.sec.gov/Archives/edgar/data/320193/000119312514277160/d740164d10q.htm

http://www.sec.gov/Archives/edgar/data/104169/000010416914000033/wmt4301410-q.htm

GRCU

Interesting Forbes article, with a point of view regarding companies in the same sphere as MultiCell:

"Still, the complex universe of biotechs is where potential giant winners are bred, as young companies with new promising medical ideas and technology undertake extensive research in search of undiscovered wonder drugs. After all, that’s where the Amgens and Gileads started before they rocketed to where they are today."

http://www.forbes.com/sites/genemarcial/2014/05/14/why-this-little-known-biotech-is-an-enticing-takeover-and-new-products-play/

The article goes on to make the following point:
"Noting that biotech acquisitions continue to rise, Benjamin says other companies in the industry that have been recently acquired, such as Santarius which Salix Pharmaceuticals (SLX%) bought in January 2014 for $2.6 billion, have been acquired at 6 to 10 times their 2014 projected revenues"

This recent Forbes article makes it clear that there is still a hot acquisition market for smaller biotech companies, and that the acquisition targets can be richly valued. All of this bodes well for companies like MultiCell, which hold valuable disease related patents and engage in associated clinical research.

As always, simply my opinion.

MCET

A $3 billion offer was tendered in 2014 for another biotech company (with minimal recent revenues to boot). Idenix is a 'biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases'. According to their 10-K filing, Idenix only had revenue of $469,000 for all of CY 2013 (see link below for filing), no revenue for Q1 or Q2 of 2014 (according to google finance), and has been bleeding money for several years.

Recently Merck tendered an offer of more than $3 billion to acquire Idenix Pharmaceuticals Inc (because of the patents they own and the research they have conducted.)

So here's an intriguing piece of info... Merck only derived about 3% of its revenue in Q1 2013 from Cancer related drugs. When an industry giant is weak in a particular area, they often use acquisitions to strengthen their weakest areas.

It would seem plausible that a company like Merck, who has already demonstrated their willingness and desire to acquire smaller companies, might eventually be willing to buy a company like MultiCell (for their research performed and patents held). And based upon the $3 billion Merck will be paying for Idenix (with little or no recent revenue), any possible offer could be rich indeed. Could you imagine how an OTC stock would react if Merck expressed some interest in owning them?

As always, simply my opinion.

Merck Completes Tender Offer to Acquire Idenix
http://www.marketwatch.com/story/merck-completes-tender-offer-to-acquire-idenix-2014-08-05

Why Did Merck Pay Such A Huge Premium For Idenix?
http://www.forbes.com/sites/greatspeculations/2014/06/12/why-did-merck-pay-such-a-huge-premium-for-idenix/


Link to Idenix Pharmaceuticals Inc 2013 10-K:
http://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/0001193125-14-073142-index.htm

MCET

Something shareholders should know about Robert Calkin...
In contrast to GRCU's employment agreements (which align the interest of shareholders with those of the company execs), several of the other OTC stocks I've owned have chosen to book a liability for the CEO's salary (i.e. salaries payable) for several quarters/years, and then the company eventually announces 'great news' via a PR that it is clearing away debt off the books.

Then those companies proceed to issue shares to the CEO to wipe the accumulated salaries payable balance off of the books. And since the stock is usually way down just prior to this 'debt satisfaction' event, the CEO ends up getting several hundred million common shares to wipe the salaries payable off of the books, because the share price is in the crapper.

If, for example, the stock was trading at .0005, a million shares would need to be issued to the CEO to satisfy each $500 owed in back salary. And 100 million shares would need to be issued to satisfy $50k in salaries payable.

By Robert Calkin accepting the static figure of 4 million shares (vested quarterly) for the 12 month period, regardless of the performance of the stock, he has demonstrated his confidence in the value of GRCU stock. And when a CEO of an OTC company demonstrates confidence and respect for the stock, the market tends to follow (because it is such a rarity in OTC land).

As always, simply my opinion.

GRCU

Some Hemp related DD

Green Cures recently announced plans for Hemp related product expansion. Below is some info relating to the enormous potential within the Hemp industry, as well as the continually improving legislative climate in the US.

Having Robert Calkin (a well respected and well connected industry veteran) at the helm, at a time when the US seems to be moving rapidly towards opening the doors wide open for this growing industry, may prove to be the 'perfect storm' for explosive investor gains in the coming months.

'Canada’s hemp economy is already worth a billion dollars annually, and it’s growing 30 percent per year. They can’t keep up with demand (especially American demand) in the field or the processors that render the profitable seed oil.'

'Hemp, Fine says, is a game changing plant that’s going to feed the world and free us from fossil fuels while putting small farmers back to work. The good news, he says, is that the roadblocks to industrial hemp cultivation are collapsing the way Communism did with the Berlin Wall.'

link: http://ecowatch.com/2014/04/25/doug-fine-u-s-hemp-ban-more-ridiculous-ddt/

'Benge sells hemp products. The oils and other products are manufactured and imported from overseas. That’s why he’s all for a bill that passed the Michigan House of Representatives.'

link: http://fox17online.com/2014/05/23/hemp-legislation-passes-the-state-house/

'So far in the 2014 legislative season, industrial hemp legislation has been introduced or carried over in thirteen states: Arizona, Hawaii, Indiana, Mississippi, Nebraska, New Jersey (carried over from 2013), New York, Oklahoma, South Carolina, Tennessee, Washington (two bills carried over from 2013), West Virginia and Wisconsin.'

link: http://ecowatch.com/2014/02/07/president-signs-farm-bill-legalizing-hemp/

As an indication of the growing demand, here's a small sampling of some of the hemp/cannabis related beverages that have been introduced to the market by others:

The winding road that brought us here...
As painful as this price consolidation near a penny is, IMO it has been a necessary evil over the past few months, for the following reasons.

During the period of Aug 2012 thru Dec 2013, GRCU (formerly TTDZ) traded in the low triple zeros (see chart below). That's 5 complete fiscal quarters of a trading range within the low triple zeros. During that extended period of time, there was least a couple billion shares traded, which represented the entire share structure for the company.

With the entire share structure having been traded in the low triple zero range between Aug 2012 and Dec 2013, there is a very high probability that the vast majority of shareholders had an entry price in the low triple zeros, prior to the price explosion.

Within the 3 month period of Jan 1 2014 and April 1 2014, the share price then ran from .0002 to 4.9 cents. That's a 240x move, which is more than 24,000%. And since that move was preceded by trading of several billion in the low triple zeros which was more than the entire share structure, the huge move upward likely left many original shareholders with huge gains from the triple zero level.

Had the share price been in the low triple zero level only briefly (as some of the OTC stocks experience prior to a huge move), there would not be a large number of shareholder sitting on gains of tens of thousands of percent. But as we know from the historical chart (see below), there was a period well in excess of a year with the stock trading in the low triple zeros for shares to be acquired.

I think it is because of this price history that we have been seeing the stock drift downward over the past few months. I believe that on most days, there's probably a couple of million shares that were originally picked up in the low triple zeros being sold at the bid. While some are questioning why would some people be selling each day with such future potential, the answer is that even around one penny, an original low triple zero buyer is clearing 20 to 50x their original purchase amount. And with an uncertain future, and a declining stock price, who could blame them.

I do believe that most of those original buyers (with an entry point in the low triple zeros) have been flushed from the system, and we should begin to see share price appreciation in the near future.

As always simply my opinion.



GRCU

Some have expressed the opinion that GRCU's OTC tier upgrade from 'OTC Pink Limited' to 'OTC Pink Current' will have no impact on the share price, within the coming days. I see it differently.

There are clearly many people that will trade/invest in an OTC stock even when the tier status is 'OTC Pink Limited' . And for those people, today's OTC tier status upgrade may have no impact.

But there are definitely some that will shy away from trading/investing in an OTC stock that is not classified as current with respect to all of their filings. And as those people are added to the GRCU bid, or begin slapping the GRCU ask, it should tip the scales in favor of share price appreciation rather than price decline.

The tier upgrade alone is not a reason to buy the stock. But for some, the old OTC tier (of limited info) was a reason not to buy, and that obstacle has now been cleared for them.

As always, simply my opinion.

GRCU

Holy $$ CBD $$ oil, batman....
Google's Trends service allows people to see the growing or diminishing interest in a topic, as a function of time.

What the chart below clearly shows is explosive growth in internet users searching for the term 'CBD oil' on the web, particularly since January 2014. IMO, Green Cures is in the right place at the right time. And with Robert Calkin at the helm, extraordinary things will begin to develop.



link:
http://www.google.com/trends/explore#q=cbd%20oil&date=1%2F2010%2055m&cmpt=q

As always, simply my opinion.

GRCU

Every so often, a movie may provide some valuable insight into the human psyche...
One of my favorite movies is Braveheart. In one of the scenes, the English King is on the battlefield, and issues an order to send in the archers. One of the king's advisers then seems a bit surprised, and asks something like (paraphrasing) 'But sir, won't we be hitting our own men.'

Then the king replies something like (paraphrasing) 'We'll be hitting the enemy as well, and we have reserves (more of our own men to replace the ones that will surely perish from the action).'

The reason I refer to this scene from Braveheart is that I think that specific calculated callousness of the English King reminds me of what OWOO did less than a year ago (back in December '13). As others here will recall, a PR was issued declaring better than expected Q4 doll sales, the paying down of some toxic convertible Asher debt, and the implementation of a share repurchase plan. Within weeks of that optimistic and encouraging announcement, they they announced a 750-1 reverse split (also in Dec '13).

When contemplating whether to execute that 750-1 R/S, I have to imagine that someone at OWOO brought up the fact that it would decimate the investment of those shareholders that have been supporting the company by 1) purchasing the stock on the open market, and 2) getting the word out to other potential investors. In other words, wouldn't the reverse split hit our own investors, just as the archer's arrows in Braveheart would be hitting their own men.

But just as the king in Braveheart was not too concerned about the carnage he would be causing to his own men (because he had reserves), OWOO mgmt must have felt that they could simply replace the old open market investors with a new wave of open market investors, after the reverse split destroyed the investment of the old investors.

Additionally, OWOO did not need to be too concerned with the extensive shareholder damage caused by the 750-1 reverse split, because mgmt was quickly issued many millions of new shares very shortly after the reverse split (the equivalent of many billions of pre reverse split shares). In other words, OWOO mgmt was not on the same field where the archer's arrows needed to be a concern. I guess one lesson here might be that arrows can sometimes act as boomerangs.

As always, simply my opinion.

.000OWOO

Some Hemp related DD

Green Cures recently announced plans for Hemp related product expansion. Below is some info relating to the enormous potential within the Hemp industry, as well as the continually improving legislative climate in the US.

Having Robert Calkin (a well respected and well connected industry veteran) at the helm, at a time when the US seems to be moving rapidly towards opening the doors wide open for this growing industry, may prove to be the 'perfect storm' for explosive investor gains in the coming months.

'Canada’s hemp economy is already worth a billion dollars annually, and it’s growing 30 percent per year. They can’t keep up with demand (especially American demand) in the field or the processors that render the profitable seed oil.'

'Hemp, Fine says, is a game changing plant that’s going to feed the world and free us from fossil fuels while putting small farmers back to work. The good news, he says, is that the roadblocks to industrial hemp cultivation are collapsing the way Communism did with the Berlin Wall.'

link: http://ecowatch.com/2014/04/25/doug-fine-u-s-hemp-ban-more-ridiculous-ddt/

'Benge sells hemp products. The oils and other products are manufactured and imported from overseas. That’s why he’s all for a bill that passed the Michigan House of Representatives.'

link: http://fox17online.com/2014/05/23/hemp-legislation-passes-the-state-house/

'So far in the 2014 legislative season, industrial hemp legislation has been introduced or carried over in thirteen states: Arizona, Hawaii, Indiana, Mississippi, Nebraska, New Jersey (carried over from 2013), New York, Oklahoma, South Carolina, Tennessee, Washington (two bills carried over from 2013), West Virginia and Wisconsin.'

link: http://ecowatch.com/2014/02/07/president-signs-farm-bill-legalizing-hemp/

As an indication of the growing demand, here's a small sampling of some of the hemp/cannabis related beverages that have been introduced to the market by others:

The genesis of the explosive price move that GRCU has had, and some of my thoughts on the subject. As painful as this price consolidation near a penny is, IMO it has been a necessary evil over the past few months, for the following reasons.

During the period of Aug 2012 thru Dec 2013, GRCU (formerly TTDZ) traded in the low triple zeros (see chart below). That's 5 complete fiscal quarters of a trading range within the low triple zeros. During that extended period of time, there was least a couple billion shares traded, which represented the entire share structure for the company.

With the entire share structure having been traded in the low triple zero range between Aug 2012 and Dec 2013, there is a very high probability that the vast majority of shareholders had an entry price in the low triple zeros, prior to the price explosion.

Within the 3 month period of Jan 1 2014 and April 1 2014, the share price then ran from .0002 to 4.9 cents. That's a 240x move, which is more than 24,000%. And since that move was preceded by trading of several billion in the low triple zeros which was more than the entire share structure, the huge move upward likely left many original shareholders with huge gains from the triple zero level.

Had the share price been in the low triple zero level only briefly (as some of the OTC stocks experience prior to a huge move), there would not be a large number of shareholder sitting on gains of tens of thousands of percent. But as we know from the historical chart (see below), there was a period well in excess of a year with the stock trading in the low triple zeros for shares to be acquired.

I think it is because of this price history that we have been seeing the stock drift downward over the past few months. I believe that on most days, there's probably a couple of million shares that were originally picked up in the low triple zeros being sold at the bid. While some are questioning why would some people be selling each day with such future potential, the answer is that even around one penny, an original low triple zero buyer is clearing 20 to 50x their original purchase amount. And with an uncertain future, and a declining stock price, who could blame them.

I do believe that most of those original buyers (with an entry point in the low triple zeros) have been flushed from the system, and we should begin to see share price appreciation in the near future.

As always simply my opinion.



GRCU

Fair point... here's my follow-up question. Consider a scenario where someone expressed interest in a plan to bomb a city. And as a result, the residents of that city began dumping their real estate holdings on the market, dropping the price of real estate there substantially. Then there was news that the bombing plan did not succeed, due to too few votes, so the residents began buying back their real estate (driving up the price several hundred percent).

But then news came out that there would be a 120 day delay in any bombing. Would...
a) those holding real estate in that city continue to hold
b) many new residents purchase real estate in that city because that time frame made them very comfortable

That hypothetical above illustrates the trouble with having confidence in holding the stock for any period of duration.

If mgmt is really determined to increase the authorized shares to 10 billion, and the current outstanding is around 138 million (with current authorized of 500 million), couldn't mgmt simply issue 140 million shares to a friendly entity (one who would vote in favor of this measure to increase the A/S), and then conduct another vote for the increase to 10 billion?

It would seem pretty simple and straight forward to do that, if there was no other way to get that increase to the authorized shares that they seem to so badly desire. And in actuality, since they already have some number of 'yes' votes, the number of new shares required to obtain a 'yes' majority may be substantially less than 140 million.

How would the share price react to the execution, or even the knowledge, of such a plan?

VIIC

Could you imagine if some large scale, reputable, publicly traded organization was causing massive destruction to shareholder value (via their direct actions), and the response to shareholders (hypothetically) was quit complaining, you crybabies. It is like some distortional parallel universe.

As always simply my opinion.

One of my favorite movies is Braveheart. In one of the scenes, the English King is on the battlefield, and issues an order to send in the archers. One of the king's advisers then seems a bit surprised, and asks something like (paraphrasing) 'But sir, won't we be hitting our own men.'

Then the king replies something like (paraphrasing) 'We'll be hitting the enemy as well, and we have reserves (more of our own men to replace the ones that will surely perish from the action).'

The reason I refer to this scene from Braveheart is that I think that specific calculated callousness of the English King reminds me of what OWOO did less than a year ago (back in December '13). As others here will recall, a PR was issued declaring better than expected Q4 doll sales, the paying down of some toxic convertible Asher debt, and the implementation of a share repurchase plan. Within weeks of that optimistic and encouraging announcement, they they announced a 750-1 reverse split (also in Dec '13).

When contemplating whether to execute that 750-1 R/S, I have to imagine that someone at OWOO brought up the fact that it would decimate the investment of those shareholders that have been supporting the company by 1) purchasing the stock on the open market, and 2) getting the word out to other potential investors. In other words, wouldn't the reverse split hit our own investors, just as the archer's arrows in Braveheart would be hitting their own men.

But just as the king in Braveheart was not too concerned about the carnage he would be causing to his own men (because he had reserves), OWOO mgmt must have felt that they could simply replace the old open market investors with a new wave of open market investors, after the reverse split destroyed the investment of the old investors.

Additionally, OWOO did not need to be too concerned with the extensive shareholder damage caused by the 750-1 reverse split, because mgmt was quickly issued many millions of new shares very shortly after the reverse split (the equivalent of many billions of pre reverse split shares). In other words, OWOO mgmt was not on the same field where the archer's arrows needed to be a concern. I guess one lesson here might be that arrows can sometimes act as boomerangs.

As always, simply my opinion.

OWOO

In my opinion, it wasn't a matter of thinking it was important. When lawyers are doing their job correctly, they try to cover anything and everything under the sun. Anyone who has ever read a contract prepared by a lawyer is very aware of that.

The US Senate and House of Reps is full of lawyers, and that is why much of the legislation drafted is as thick as a phone book.

As always, simply my opinion.

I posted this statement (below in blue) back in April, and I think it is along the same lines as what you have just stated very eloquently ...

'Months from now, after many more 'positive developments' are communicated to the investing public by those at OWOO, they will likely ask themselves the following question.

With so many seemingly positive developments inside the company, why has the investment community not embraced our stock. And by embraced, I mean a sustained price increase, where investors/traders are not running to the exits on any significant pop.

After some internal reflection, they may come to the realization that investors will not respect a stock that is not shown respect by those running the company. It would seem to me that they have not come to this realization yet.

As always, simply my opinion.'

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=100605341

It should be no surprise to anyone that Robert Calkin worked diligently to get the necessary Attorney letter submitted to the OTC in an expeditious fashion. It is but one more sign of the seriousness of his plans. As another indicator, I would like to remind all here of the shareholder friendly terms of his annual employment agreement.

In contrast to GRCU's employment agreements (which align the interest of shareholders with those of the company execs), several of the other OTC stocks I've owned have chosen to book a liability for the CEO's salary (i.e. salaries payable) for several quarters/years, and then the company eventually announces 'great news' via a PR that it is clearing away debt off the books.

Then those companies proceed to issue shares to the CEO to wipe the accumulated salaries payable balance off of the books. And since the stock is usually way down just prior to this 'debt satisfaction' event, the CEO ends up getting several hundred million common shares to wipe the salaries payable off of the books, because the share price is in the crapper.

If, for example, the stock was trading at .0005, a million shares would need to be issued to the CEO to satisfy each $500 owed in back salary. And 100 million shares would need to be issued to satisfy $50k in salaries payable.

By Robert Calkin accepting the static figure of 4 million shares (vested quarterly) for the 12 month period, regardless of the performance of the stock, he has demonstrated his confidence in the value of GRCU stock. And when a CEO of an OTC company demonstrates confidence and respect for the stock, the market tends to follow (because it is such a rarity in OTC land).

As always, simply my opinion.

GRCU

As long as there is a trading symbol (ticker) and there is any sort of trading volume, the only certainty here is that there is a greater than zero chance that the stock could rise.

Determining what is the reasonable probability of that occurring, and how high it might go, is what separates those with consistent gains from those with consistent losses. From my experience, timing is the single most important factor in the OTC.

The following is revealed in DKGR's financial statements ended Jun 30 '14:
DKGR has positive cash flow from operations for the six months ended June 30 2014. Why is this important? Because when OTC companies are cash flow negative, they usually make up for the cash flow deficit by taking on toxic funding, via convertible notes. And as we know, when those notes convert (at a discount to market share prices), the downward pressure on the stock is tremendous.

Cash flow positive companies can sustain operations without dependence upon toxic lenders. When an OTC company is not dependent upon toxic lenders, it provides an environment in which a share price may flourish, particularly in the OTC world.

As always, simply my opinion.

DKGR

An important lesson I'll not soon forget...

Nte* had a huge run, from deep in the subpennies to about 3 cents, and then painfully drifted back to around a penny a share (during a period of about 5 months). On May 21 2013, when that stock was momentarily dipping below a penny, here is what some of the less positive posts looked like:

- TIMBER!!! NTE* and the ...
- It's been bottoming out for 4 months...
- Overvalued. By a factor of 30
- Uh oh................what's that I see on the bid?

Some undoubtedly were swayed by the crescendo of negative sentiment, and released their shares at that level, just below a penny a share.

Others held through the storm, and were very glad they did. Less than two months later (by early July of 2013), the stock not only stopped the bleeding, but ran to over a dime a share, up more than 1000% from the level it was at on May 21 '13 when it dipped below a penny.

I'm not going to deny the possibility that GRCU could continue to slide lower, while Calkin continues to move the pieces into place. But I'll not soon forget the lesson above with Nte*.

As always, simply my opinion.

GRCU

Yes Neuronal. In a market with frenetic trades in and out, where a month is considered a very long-term hold by many, patience can indeed pay off nicely.

BTW, congrats to you on FIT*. A 100x move up from the bottom, and it has held much of that appreciation for quite some time.

Below is the 2 year price chart on MSLP. Every single share that was bought (and held) in MSLP between 8/27/12 and 8/26/14 (the past 730 days) has appreciated in price. Congrats to those that tuned out the static, and focused on the growth story and brand penetration.



MSLP

With a current market cap of under $100 million, RSH is valued at less than .03x (3%) annual sales. If there is even the hint of final acceptance of a viable plan for a turnaround here (such as a definitive agreement reached with debt holders to allow for the accelerated closure of a large # of under-performing stores), this stock will go much higher.

As always, simply my opinion.

RSH

Idenix is a 'biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases'. According to their 10-K filing, Idenix only had revenue of $469,000 for all of CY 2013 (see link below for filing), no revenue for Q1 or Q2 of 2014 (according to google finance), and has been bleeding money for several years.

Recently Merck tendered an offer of more than $3 billion to acquire Idenix Pharmaceuticals Inc (because of the patents they own and the research they have conducted.)

So here's an intriguing piece of info... Merck only derived about 3% of its revenue in Q1 2013 from Cancer related drugs. When an industry giant is weak in a particular area, they often use acquisitions to strengthen their weakest areas.

It would seem plausible that a company like Merck, who has already demonstrated their willingness and desire to acquire smaller companies, might eventually be willing to buy a company like MultiCell (for their research performed and patents held). And based upon the $3 billion Merck will be paying for Idenix (with little or no recent revenue), any possible offer could be rich indeed. Could you imagine how an OTC stock would react if Merck expressed some interest in owning them?

As always, simply my opinion.

Merck Completes Tender Offer to Acquire Idenix
http://www.marketwatch.com/story/merck-completes-tender-offer-to-acquire-idenix-2014-08-05

Why Did Merck Pay Such A Huge Premium For Idenix?
http://www.forbes.com/sites/greatspeculations/2014/06/12/why-did-merck-pay-such-a-huge-premium-for-idenix/


Link to Idenix Pharmaceuticals Inc 2013 10-K:
http://www.sec.gov/Archives/edgar/data/1093649/000119312514073142/0001193125-14-073142-index.htm

MCET

Agreed, tob999. Simply stated, the technology that MultiCell has developed would not only effectively target cancer cells, but also provide the patient with some sort of preventive shield against the formation of new tumors.

You're welcome. The interesting thing is that in most industries, a company would need to have significant revenues, or a well known brand name, to be of any value to a potential suitor.

But in the pharmaceutical business, it is a whole different ball game. The right research & development combined with the right patent(s) can result in a huge buyout offer from one of the big players. Sometimes they'll make a huge offer just to keep one of their major competitors from getting the patent(s).

I think we might see some excitement here in the coming days.

A always, simply my opinion.